CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

human placental derived stem cells

Cell therapyexperimental

Clinical trial activity

32 trials · 40 clinical orgs · 0 marketing orgs

Phase 1
19
Phase 2
12
Phase 3
3
Phase 4
0

Earliest trial started Aug 31, 2002 (NCT00130377)

Timeline

2000s

  1. Jan 1, 2002

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2012

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • human placenta-derived cells
  • human placental derived stem cells
  • placenta derived mesenchymal stem cell
  • placental matrix-derived mesenchymal stem cells
  • plx-r18

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07158658N/ANov 13, 2025NuScience Medical Biologics, LLC, SygNola, LLC
NCT07061613N/ASep 2, 2025NuScience Medical Biologics, LLC, SygNola, LLC
NCT07039396N/AAug 26, 2025NuScience Medical Biologics, LLC, SygNola, LLC
NCT06671275Phase 1Jun 21, 2024Anhui Medical University, University of Science and Technology of China
NCT06096038Phase 1/Phase 2 (Phase 2)Dec 31, 2023Bellicum Pharmaceuticals, University of North Carolina at Chapel Hill
NCT06296095Phase 1Aug 9, 2023Anhui Medical University
NCT06373809Early Phase 1 (Phase 1)Oct 8, 2021government of nicaragua, Wake Forest University
NCT04804891Phase 1Sep 30, 2021Columbia University, Ossium Health, Inc.
NCT04652908Phase 1/Phase 2 (Phase 2)Jun 21, 2021California Institute for Regenerative Medicine (CIRM), University of California, Davis
NCT04464213Phase 1Nov 1, 2020Capital Medical University
NCT04453111Phase 1/Phase 2 (Phase 2)Jan 2, 2020Institute of Cell Therapy, Kyiv City Clinical Hospital № 6, The Institute of Traumatology and Orthopedics of NAMS of Ukraine
NCT03877471Phase 1Apr 3, 2019Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Zhengzhou University
NCT03797040Phase 1Jan 1, 2019Pluristem Ltd.
NCT03536013N/AMay 3, 2018Polaris Spine and Neurosurgery, StimLabs
NCT02434965Phase 2Aug 1, 2017Celgene, New York Medical College
NCT03002519Phase 1Feb 8, 2017Pluristem Ltd.
NCT03028428Phase 2Dec 1, 2016Nanjing Medical University
NCT02923609Phase 2Jan 31, 2016University of Ljubljana
NCT07187362Phase 2/Phase 3 (Phase 3)Oct 13, 2015Midwest Spine & Brain Institute
NCT01935635Phase 1/Phase 2 (Phase 2)Jan 1, 2015Jiao Tong University, Second People's Hospital of Yunnan Province, Sun Yat-Sen University
Showing 20 of 32 trials
Page 1 / 2

Organizations

Research & Development (40)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
CelgeneFor profit5422010
NuScience Medical Biologics, LLCFor profit3312025
SygNola, LLCFor profit3012025
Anhui Medical UniversityAcademic/Hospital2212023
New York Medical CollegeAcademic/Hospital2222013
Pluristem Ltd.For profit2212017
Z UrologyAcademic/Hospital2212013
Assistance Publique - Hôpitaux de ParisAcademic/Hospital1112010
Bellicum PharmaceuticalsFor profit1012023
California Institute for Regenerative Medicine (CIRM)Academic/Hospital1012021
Capital Medical UniversityAcademic/Hospital1112020
Chinese Academy of Medical SciencesAcademic/Hospital1112019
Chinese People's Armed Police ForcesGovernment1012012
Columbia UniversityAcademic/Hospital1112021
General Hospital of Chinese Armed Police ForcesAcademic/Hospital1112012
government of nicaraguaAcademic/Hospital1012021
Institute of Cell TherapyAcademic/Hospital1112020
Jiao Tong UniversityAcademic/Hospital1012015
Kyiv City Clinical Hospital № 6Academic/Hospital1012020
Mater Medical Research InstituteAcademic/Hospital1012010
40 organizations
Page 1 / 2